VCU Medical Center
Richmond, Virginia 23298-0631
10 studies enrolling now · 49 studies all time
What they study most
Acute Coronary Syndromes, Acute Decompensated Heart Failure, Acute Liver Failure, Acute Respiratory Distress Syndrome, Acute Respiratory Infection, Amyloidosis, Amyotrophic Lateral Sclerosis, Aortic Stenosis, Atrial Fibrillation, Benzodiazepine Refractory Status Epilepticus, Blood Loss, Postoperative, Blood Loss, Surgical
Studies at this site
- A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) — Recruiting now
- Strategy for Improving Stroke Treatment Response — Recruiting now
- Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) — Recruiting now
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
- SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy. — Recruiting now
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
- Nimodipine Variability in SAH — Recruiting now
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) — Recruiting now
- Pulmonary Hypertension Association Registry — Recruiting now
- Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
- Screening for AL Amyloidosis in Smoldering Multiple Myeloma — Recruiting now
- Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients — Completed
- A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis — Running, not enrolling
- Brain Oxygen Optimization in Severe TBI, Phase 3 — Running, not enrolling
- De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients — Running, not enrolling
- Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial — Running, not enrolling
- Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
- Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D) — Stopped early
- Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T) — Completed
- Carmat TAH Early Feasibility Study — Paused
- Glyburide (RP-1127) for Traumatic Brain Injury (TBI) — Completed
- Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery — Completed
- Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
- Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis — Completed
- Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) — Status unconfirmed
- HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network — Completed
- C-Pulse® System: A Heart Assist Device Clinical Study — Stopped early
- A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes — Paused
- Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis — Completed
- AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
- AO Multicenter Intervention Trial for Prevention of Surgical Site Infection — Stopped early
- Awake Prone Position for Early Hypoxemia in COVID-19 — Completed
- Established Status Epilepticus Treatment Trial — Completed
- Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease — Completed
- 13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF — Completed
- Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) — Stopped early
- Vitamin D to Improve Outcomes by Leveraging Early Treatment — Completed
- Reevaluation Of Systemic Early Neuromuscular Blockade — Completed
- Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage — Stopped early
- Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy — Completed
- Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1 — Completed
- Safety Study of Preservon-Treated Bone Implants for Cervical Fusion in the Treatment of Cervical Radiculopathy or Myelopathy — Completed
- Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection — Completed
- Spondylolisthesis Treated With an iO-Flex® System Enabled Decompression — Status unconfirmed
- Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
- Ulimorelin Study of Efficacy and Safety (ULISES 008) — Completed
- Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation — Stopped early
- Conservation of Red Cell Mass , Oxygen Supply and Demand in Cardiac Surgery — Completed